SHOX2 and prostate carcinoma: These methods can identify tissue-specific methylation patterns that are highly enriched in cancer, such as those in SEPT9 (colorectal cancer) [39], SHOX2 (lung cancer) [40,41], and GSTP1 (prostate cancer) [42,43].